PI3K/AKT signaling pathway activation is associated with an anti-apoptotic function, and the inhibition of the PI3K/AKT pathway contributes to NAFLD development37. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.